Global Biopharma CEO/Top Executives COVID-19 Media Briefing

Statement 28 Feb 2023

Industry statement at fourth meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

On 28 February, IFPMA delivered a statement at the fourth meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response held from 27 February - 3 March 2023.

Second meeting of the Working Group on Amendments to the International Health Regulations (2005) (WGIHR)

On 21 February, IFPMA delivered a statement at the second meeting of the Working Group on amendments to the International Health Regulations (2005) (WGIHR) held from 20-24 February 2023.

Strengthening the global architecture for health emergency preparedness, response, and resilience (EB152)

IFPMA delivered a constituency statement for the agenda item related to strengthening the global architecture for health emergency preparedness, response, and resilience at the 152nd session of the Executive Board at the World Health Organization in Geneva.